219 related articles for article (PubMed ID: 32286474)
1. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses.
Jiang Z; Fu L; Xu Y; Hu X; Yang H; Zhang Y; Luo H; Gan S; Tao L; Liang G; Shen X
Sci Rep; 2020 Apr; 10(1):6427. PubMed ID: 32286474
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
4. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G
Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616
[TBL] [Abstract][Full Text] [Related]
6. Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis
Gao G; Fu L; Xu Y; Tao L; Guo T; Fang G; Zhang G; Wang S; Qin T; Luo P; Shen X
Front Pharmacol; 2022; 13():906548. PubMed ID: 35865939
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
8. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
10. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation.
Hao J; Zhou J; Hu S; Zhang P; Wu H; Yang J; Zhao B; Liu H; Lin H; Chi J; Lou D
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C331-C347. PubMed ID: 38047307
[TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
12. Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway.
Ma W; Guo W; Shang F; Li Y; Li W; Liu J; Ma C; Teng J
Oxid Med Cell Longev; 2020; 2020():3732718. PubMed ID: 33062139
[TBL] [Abstract][Full Text] [Related]
13. Cinnamaldehyde Ameliorates High-Glucose-Induced Oxidative Stress and Cardiomyocyte Injury Through Transient Receptor Potential Ankyrin 1.
Wang D; Hou J; Yang Y; Zhou P; Liu S; Wan J; Wang P
J Cardiovasc Pharmacol; 2019 Jul; 74(1):30-37. PubMed ID: 31274840
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology-Based Strategy Reveals the Effects of
Zhang S; Yuan Z; Wu H; Li W; Li L; Huang H
Biomed Res Int; 2020; 2020():8260703. PubMed ID: 33134388
[TBL] [Abstract][Full Text] [Related]
15. Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF‑κB signalling pathway in diabetic cardiomyopathy rats.
Jin Q; Zhu Q; Wang K; Chen M; Li X
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495841
[TBL] [Abstract][Full Text] [Related]
16. Blockage of ROS and NF-κB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries.
Zhong P; Wu L; Qian Y; Fang Q; Liang D; Wang J; Zeng C; Wang Y; Liang G
Biochim Biophys Acta; 2015 Jul; 1852(7):1230-41. PubMed ID: 25736300
[TBL] [Abstract][Full Text] [Related]
17. Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cells.
Shinjo T; Tanaka T; Okuda H; Kawaguchi AT; Oh-Hashi K; Terada Y; Isonishi A; Morita-Takemura S; Tatsumi K; Kawaguchi M; Wanaka A
PLoS One; 2018; 13(4):e0196191. PubMed ID: 29689082
[TBL] [Abstract][Full Text] [Related]
18. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
Chang X; Lu K; Wang L; Lv M; Fu W
Biosci Trends; 2018 May; 12(2):149-156. PubMed ID: 29607874
[TBL] [Abstract][Full Text] [Related]
19. The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling.
Gao Y; Liu W; Su X; Li X; Yu F; Zhang N
Oxid Med Cell Longev; 2022; 2022():3959390. PubMed ID: 35656019
[TBL] [Abstract][Full Text] [Related]
20. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]